ライフサイエンスコーパス: pathologic analysis

1 to be in complete remission by conventional pathologic analysis.

2 t an ex vivo tumorectomy with a preoperatory pathologic analysis.

3 uated in real time and compared with classic pathologic analysis.

4 imaging were without tumor at trachelectomy pathologic analysis.

5 benign, yet current practice requires costly pathologic analysis.

6 t one transition zone cancer at step-section pathologic analysis.

7 ntitis at clinical analysis and granuloma at pathologic analysis.

8 ssification was compared with the results of pathologic analysis.

9 CT but nonspecific interstitial pneumonia at pathologic analysis.

10 thus promises to extend and refine standard pathologic analysis.

11 On pathologic analysis, 24% of specimens were T0.

12 At pathologic analysis, 28 (4.9%) of 573 patients had SVI.

13 On pathologic analysis, 36 patients (8.9%) had steatosis, 3

14 At pathologic analysis, 74 (80%) of the 93 lesions were mal

15 At pathologic analysis, acute lesions appeared as pale necr

16 2%] with visceral pleural invasion proved by pathologic analysis and 97 patients [68.8%] without pleu

17 on coefficients of lesion diameters at gross pathologic analysis and corresponding diameters with eac

18 e follow-up, eyes were collected for further pathologic analysis and nuclei cell counts.

19 driven molecular imaging is complementary to pathologic analysis and offers a more direct measure of

20 lecular tests, immunohistochemical analysis, pathologic analysis, and electron microscopy.

21 Four patients had periapical abscesses at pathologic analysis, and the fifth patient had apical pe

22 T but desquamative interstitial pneumonia at pathologic analysis; and one patient, with lymphoid inte

23 Thermal lesion diameters measured at gross pathologic analysis best agreed with corresponding diame

24 y has the potential to provide rapid bedside pathologic analysis, but clinical adoption has been limi

25 section pathology maps were used for imaging-pathologic analysis correlation.

26 at disease onset in GL3-treated animals, and pathologic analysis demonstrated a marked reduction in m

27 Pathologic analysis demonstrated decreased lung injury i

28 Pathologic analysis demonstrated decreased lung injury i

29 Among the 416 patients with NSCLC, pathologic analysis demonstrated stage I in 330 patients

30 Final diagnosis was established with pathologic analysis for all endometriomas and neoplasms.

31 the data validating DE MR imaging, in which pathologic analysis has shown the precise shape and cont

32 US-guided FNA findings, results of surgical-pathologic analysis helped confirm the cytologic diagnos

33 Radiographs of the specimen and pathologic analysis helped verify target and reflector r

34 Pathologic analysis included primary NSCLC in 416 patien

35 hanisms, 39 mice were sacrificed for blinded pathologic analysis, including assessment of DNA damage,

36 considered to have responded if its stage at pathologic analysis indicated regression compared with t

37 In pathologic analysis, ISX exhibited a tumor-specific expr

38 On final pathologic analysis, margin status was positive in 45 pa

39 Hemorrhagic cysts were diagnosed with pathologic analysis (n = 7), follow-up imaging (n = 13),

40 of ELSTs, we did a morphologic and molecular pathologic analysis of 16 tumors.

41 A comprehensive clinical and pathologic analysis of 48 patients with GISTs who had sn

42 prospective use of a standardized system for pathologic analysis of all PD specimens.

43 Pathologic analysis of benign lesions was performed on t

44 ning in patients undergoing biopsy was final pathologic analysis of biopsy specimens or follow-up ima

45 echocardiography as well as by molecular and pathologic analysis of heart samples in infarct, peri-in

46 Pathologic analysis of human glioma specimens revealed t

47 Pathologic analysis of Mtm1delta4 mice during treatment

48 esponse based on routine immunohistochemical pathologic analysis of random post-treatment gastric bio

49 ce, the procedure times were measured, and a pathologic analysis of the biopsy cores was performed.

50 Pathologic analysis of the liver resection specimens was

51 These data underscore the need for careful pathologic analysis of the SLN as well as a careful, dir

52 te cancer and make recommendations about the pathologic analysis of these models.

53 At surgical-pathologic analysis, one (0.6%) patient had no cancer; 1

54 t with nonspecific interstitial pneumonia at pathologic analysis; one patient, with nonspecific inter

55 minations at 3.0 T and either had received a pathologic analysis-proven diagnosis (96 lesions) or had

56 Pathologic analysis resulted in the diagnosis of four du

57 n, and the image findings were compared with pathologic analysis results.

58 Pathologic analysis revealed that complete interatrial c

59 Both opted for surgery, with pathologic analysis revealing organ-confined disease and

60 s not include margin-controlled excision, or pathologic analysis reveals an infiltrative subtype.

61 Gross pathologic analysis showed gradual device resorption unt

62 Pathologic analysis showed that treated hearts exhibited

63 Our comprehensive pathologic analysis suggests that, following preoperativ

64 tudy were to use a comprehensive whole-mount pathologic analysis to characterize microscopic patterns

65 Pathologic analysis was performed as the reference stand

66 Whole-mount pathologic analysis was performed, and clinicopathologic

67 Comprehensive whole-mount pathologic analysis was performed, with particular empha

68 Pathologic analysis was reviewed.

69 For the 29 patients in whom material for pathologic analysis was still available, additional neur

70 ted with respect to SVI prediction; surgical pathologic analysis was used as the reference standard.

71 use of atypia or discordance, final surgical pathologic analysis was used for correlation with imagin

72 Four of 12 VX-2 tumors detected with pathologic analysis were detected with US alone; the rem

73 Patients with a single HCC </=2 cm on pathologic analysis were included.

74 umor identified subsequently at step-section pathologic analysis were retrospectively reviewed.

75 The authors performed detailed radiologic-pathologic analysis while blinded to subsequent follow-u

76 ell or papillary RCC renal cell carcinoma at pathologic analysis, who underwent contrast material-enh